Literature DB >> 3812693

Flow of water between aqueous and vitreous compartments in the rabbit eye.

D M Maurice.   

Abstract

When fluoresceinated dextran (FD) is injected into the vitreous body of the rabbit, it diffuses out of the eye through the anterior chamber so that the ratio of its concentration in the aqueous to that in the vitreous humor remains constant. The rate of loss of the substance from the eye suggests that the vitreous body is stagnant. After penetrating the vitreous body with a 25-gauge needle through the sclera, the FD fluorescence in the aqueous humor is reduced by a factor of three times on the average. This appears to be because the loss of fluid out of the scleral hole sets up a backward seepage of fluid through the anterior vitreous body, which opposes the diffusion of dextran into the anterior chamber. In contrast, making a needle hole has little effect on the level of sulforhodamine B, a more rapidly diffusing molecule, when it has been injected into the vitreous body, and none at all when it has been introduced into the cornea. The changes in the flow across the aqueous-vitreous interface, as well as the changes in aqueous outflow after an experimental intervention to the eye, may be estimated from a comparison of the changes in fluorescence in the anterior chamber of large and small molecular weight compounds injected into the vitreous body.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3812693     DOI: 10.1152/ajprenal.1987.252.1.F104

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Computer simulation of convective and diffusive transport of controlled-release drugs in the vitreous humor.

Authors:  Matthew S Stay; Jing Xu; Theodore W Randolph; Victor H Barocas
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

2.  Hydraulic flow and vascular clearance influences on intravitreal drug delivery.

Authors:  Paul J Missel
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

Review 3.  [Seasonal variation in the occurrence of rhegmatogenous retinal detachment at the beginning of the 21st century. Study results and literature review].

Authors:  T Bertelmann; M Cronauer; B Stoffelns; W Sekundo
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

4.  Development of a physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies in rabbits.

Authors:  David Bussing; Dhaval K Shah
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-09-02       Impact factor: 2.745

5.  Permeability and diffusion in vitreous humor: implications for drug delivery.

Authors:  J Xu; J J Heys; V H Barocas; T W Randolph
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

6.  Simulating dissolution of intravitreal triamcinolone acetonide suspensions in an anatomically accurate rabbit eye model.

Authors:  Paul J Missel; Marc Horner; R Muralikrishnan
Journal:  Pharm Res       Date:  2010-05-14       Impact factor: 4.200

7.  Effects of subconjunctival 5-fluorouracil injections on the corneal endothelium and ciliary epithelium.

Authors:  M Araie; Y Nakano; T Akahoshi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

8.  Effect of multiple injections of small divided doses vs single injection of intravitreal bevacizumab on retinal neovascular model in rabbits.

Authors:  Saloomeh Saati; Rajat N Agrawal; Stan Louie; Gerald J Chader; Mark S Humayun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-31       Impact factor: 3.117

9.  Origin and renewal of the intrinsic glycoproteins of the aqueous humor.

Authors:  A Haddad; E M Laicine; J C de Almeida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

10.  Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury.

Authors:  Bruce A Berkowitz; Robin Roberts; Hongmei Luan; David Bissig; Bang V Bui; Marius Gradianu; David J Calkins; Algis J Vingrys
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.